Breast MRI as an adjunct to mammography: Does it really suffer from low specificity? a retrospective analysis stratified by mammographic BI-RADS classes

Background: Reports on the specificity of breast MRI are heterogeneous, depending on the respective setting of the performed study. Purpose: To retrospectively estimate the sensitivity and especially the specificity of breast MRI in the non-screening setting as an adjunct to mammography sorted by breast density and to estimate the accuracy of breast MRI in cases rated BI-RADS 0 and 3 mammographically. Material and Methods: A total of 216 consecutive patients with referral to breast MRI and previously acquired mammography were enrolled in this analysis. Negative findings were followed up with a mean time of 26.7 months. The loss to follow-up was 10.8%. The single breast was regarded as the study subject (n=399, 364 cases were eligible for calculation of diagnostic accuracy). BI-RADS 1 and 2 were rated as benign, 4 and 5 as malignant. BI-RADS 0 and 3 were analyzed separately. The 95% confidence intervals (CIs) were calculated from the normally approximated binomial distribution and taken to represent significant differences for the two imaging modalities if they did not overlap. Results: Among the study population, 62 malignant neoplasms were detected. For cases rated BI-RADS 1, 2, 4, and 5 (n=251), the sensitivity of breast MRI was 95.7% (95% CI 89.9–100.0%) and 74.5% (95% CI 62.0–87.0%) for mammography, respectively. The specificity of breast MRI was 96.1% (95% CI 93.4–98.8%) and 92.2% (95% CI 88.5–95.9%) for mammography, respectively. The diagnostic accuracy of breast MRI did not depend on breast density. In cases rated BI-RADS 0, n=57 (3, n=56), breast MRI achieved a sensitivity of 100% (90.9%) and a specificity of 98.1% (88.9%). There was a significant (P< 0.01) accumulation of dense breast tissue (ACR IV) in breasts rated BI-RADS 0 in mammography. Breast MRI missed three malignant lesions, two of them being smaller than 3 mm. Conclusion: There is no rationale to criticize the low specificity of breast MRI when used as an adjunct to mammography. The independency of the diagnostic accuracy of breast MRI from breast density makes it a worthwhile choice in mammographic BI-RADS 0 cases.

[1]  N. Schenker,et al.  Overlapping confidence intervals or standard error intervals: What do they mean in terms of statistical significance? , 2003, Journal of insect science.

[2]  R. Fimmers,et al.  Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  Daniel Vanel,et al.  BIRADS classification in mammography. , 2007, European journal of radiology.

[4]  Carlo Catalano,et al.  The Challenge of Imaging Dense Breast Parenchyma: Is Magnetic Resonance Mammography the Technique of Choice? A Comparative Study With X-Ray Mammography and Whole-Breast Ultrasound , 2009, Investigative radiology.

[5]  C. Kuhl.  Current status of breast MR imaging. Part 2. Clinical applications. , 2007, Radiology.

[6]  D. Rennie,et al.  Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative , 2003, BMJ : British Medical Journal.

[7]  Jean B. Cormack,et al.  Diagnostic accuracy of digital versus film mammography: exploratory analysis of selected population subgroups in DMIST. , 2008, Radiology.

[8]  Rebecca S Lewis,et al.  Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. , 2004, Radiology.

[9]  S E Harms,et al.  MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. , 1993, Radiology.

[10]  D. Miglioretti,et al.  Individual and Combined Effects of Age, Breast Density, and Hormone Replacement Therapy Use on the Accuracy of Screening Mammography , 2003, Annals of Internal Medicine.

[11]  Ellen Warner,et al.  Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination , 2004, JAMA.

[12]  A C Sims,et al.  Importance of a high tracing-rate in long-term medical follow-up studies. , 1973, Lancet.

[13]  Linda Moy,et al.  Is breast MRI helpful in the evaluation of inconclusive mammographic findings? , 2009, AJR. American journal of roentgenology.

[14]  Massimo Bazzocchi,et al.  Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in Fatty and dense breasts using the whole-breast pathologic examination as a gold standard. , 2004, AJR. American journal of roentgenology.

[15]  S. Lange,et al.  Variation of sensitivity, specificity, likelihood ratios and predictive values with disease prevalence by H. Brenner and O. Gefeller, Statistics in Medicine, 16, 981-991 (1997) , 1998, Statistics in medicine.

[16]  Joann G. Elmore,et al.  Screening for breast cancer. , 1995, JAMA.

[17]  A R Padhani,et al.  Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS) , 2005, The Lancet.

[18]  I. Imaz,et al.  Overall Breast Density in MR Mammography: Diagnostic and Therapeutic Implications in Breast Cancer , 2006, Journal of computer assisted tomography.

[19]  David Moher,et al.  Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. , 2004, Family practice.

[20]  C. Kuhl.  The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. , 2007, Radiology.

[21]  C. Kuhl,et al.  Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? , 1999, Radiology.

[22]  H Brenner,et al.  Variation of sensitivity, specificity, likelihood ratios and predictive values with disease prevalence. , 1997, Statistics in medicine.

[23]  D. Plewes,et al.  Systematic Review: Using Magnetic Resonance Imaging to Screen Women at High Risk for Breast Cancer , 2008, Annals of Internal Medicine.

[24]  S. Orel,et al.  Who should have breast magnetic resonance imaging evaluation? , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  Screening for breast cancer. , 1978, Canadian Medical Association journal.

[26]  W. Kaiser,et al.  MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations. , 1989, Radiology.

[27]  D B Plewes,et al.  Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  D. Altman,et al.  Statistics Notes: Diagnostic tests 2: predictive values , 1994, BMJ.

[29]  J. Folkman.  Clinical Applications of Research on Angiogenesis , 1995 .

[30]  W. Kaiser,et al.  Development, standardization, and testing of a lexicon for reporting contrast‐enhanced breast magnetic resonance imaging studies , 2001, Journal of magnetic resonance imaging : JMRI.